These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 11145658)

  • 1. Role of CD40 in a T cell-mediated negative regulation of Ig production.
    Majlessi L; Bordenave G
    J Immunol; 2001 Jan; 166(2):841-7. PubMed ID: 11145658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of alternative or concomitant use of perforin- and Fas-dependent pathways in a T cell-mediated negative regulation of Ig production.
    Majlessi L; Bordenave G
    J Immunol; 1999 Apr; 162(8):4391-8. PubMed ID: 10201974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-overlapping Fas- and BCL-2-regulated death pathways in IgG2a(b)-producing B cells.
    Majlessi L; Bordenave G
    Int Immunol; 2000 Jul; 12(7):969-76. PubMed ID: 10882408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.
    Majlessi L; Bordenave G
    Arch Immunol Ther Exp (Warsz); 2001; 49(6):407-15. PubMed ID: 11814234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The T/B cell interaction involved in induction of the mouse IgG2ab suppression is restricted by major histocompatibility complex class I, but not class II molecules.
    Majlessi L; Bordenave G
    Eur J Immunol; 1997 Jun; 27(6):1346-52. PubMed ID: 9209483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell-induced Ig allotypic suppression in mice. II. Both CD4+ CD8- and CD4- CD8+ T cell subsets from sensitized Igha mice are required to induce suppression of Igh-1b allotype expression.
    Benaroch P; Bordenave G
    J Immunol; 1989 Jan; 142(1):1-7. PubMed ID: 2521230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Igh-1b-specific CD4+CD8- T cell clones of the Th1 subset selectively suppress the Igh-1b allotype in vivo.
    Bartnes K; Hannestad K
    Eur J Immunol; 1991 Oct; 21(10):2365-71. PubMed ID: 1680695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central tolerance induction in natural immunoglobulin-allotype-specific T cells.
    Majlessi L; Sellier C; Bordenave G
    Eur J Immunol; 2000 Dec; 30(12):3487-97. PubMed ID: 11093168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble antigen and CD40 triggering are sufficient to induce primary and memory cytotoxic T cells.
    Lefrançois L; Altman JD; Williams K; Olson S
    J Immunol; 2000 Jan; 164(2):725-32. PubMed ID: 10623816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular induction of chronic allotype suppression of IgG2a in Ighb/b homozygous mice and its abrogation by in vivo treatment with anti-CD8 monoclonal antibody.
    Benaroch P; Georgatsou E; Bordenave G
    J Exp Med; 1988 Sep; 168(3):891-904. PubMed ID: 2902183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential requirements for expression of CD80/86 and CD40 on B cells for T-dependent antibody responses in vivo.
    Lumsden JM; Williams JA; Hodes RJ
    J Immunol; 2003 Jan; 170(2):781-7. PubMed ID: 12517941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40 signaling replaces CD4+ lymphocytes and its blocking prevents chronic rejection of heart transplants.
    Fischbein MP; Ardehali A; Yun J; Schoenberger S; Laks H; Irie Y; Dempsey P; Cheng G; Fishbein MC; Bonavida B
    J Immunol; 2000 Dec; 165(12):7316-22. PubMed ID: 11120867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway.
    Ito H; Kurtz J; Shaffer J; Sykes M
    J Immunol; 2001 Mar; 166(5):2970-81. PubMed ID: 11207246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD154 costimulation.
    Ensminger SM; Spriewald BM; Sorensen HV; Witzke O; Flashman EG; Bushell A; Morris PJ; Rose ML; Rahemtulla A; Wood KJ
    J Immunol; 2001 Jul; 167(1):532-41. PubMed ID: 11418692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
    Hirohata S
    Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide modulation of dendritic cells is insufficient to mature dendritic cells to generate CTLs from naive polyclonal CD8+ T cells in vitro, whereas CD40 ligation is essential.
    Kelleher M; Beverley PC
    J Immunol; 2001 Dec; 167(11):6247-55. PubMed ID: 11714787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superantigen-driven, CD8+ T cell-mediated down-regulation: CD95 (Fas)-dependent down-regulation of human Ig responses despite CD95-independent killing of activated B cells.
    Stohl W; Lynch DH; Starling GC; Kiener PA
    J Immunol; 1998 Oct; 161(7):3292-8. PubMed ID: 9759844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CD4+ and CD8+ cell subsets during amplification of natural T cell activity against IgG2ab in Igha mice and during induction of IgG2ab allotype suppression in Igha/b mice.
    Majlessi L; Benaroch P; Denoyelle C; Bordenave G
    J Immunol; 1993 Aug; 151(4):1859-67. PubMed ID: 8102153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells.
    Cerutti A; Schaffer A; Goodwin RG; Shah S; Zan H; Ely S; Casali P
    J Immunol; 2000 Jul; 165(2):786-94. PubMed ID: 10878352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncollagenous 16A domain of type XVII collagen-reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid model.
    Ujiie H; Shibaki A; Nishie W; Shinkuma S; Moriuchi R; Qiao H; Shimizu H
    Clin Immunol; 2012 Feb; 142(2):167-75. PubMed ID: 22044750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.